As the nation reeled from covid-19, the federal government sent many Americans a financial lifeline.
Vertex makes money from sickle cell therapy Casgevy
Vertex said it made $2 million in revenue from the first patient who received its sickle cell therapy Casgevy. The commercial launches of Casgevy and